-transparent.png){kind=logo}
Tryptic digests of recombinant TIMP-1 have been resolved on reverse-phase HPLC and the major peaks identified by N-terminal sequencing. This procedure accounted for the entire molecule, except two short peptides of 2 and 4 amino acids in length. The peptide map was used to (i), characterize an insoluble 'core' peptide seen on digestion of TIMP-1 in non-reducing conditions; (ii), confirm the structure of delta 127-184TIMP-1, a recently described truncated form of the TIMP-1 molecule; (iii), identify exposed regions of the intact and truncated TIMP-1 molecules by measuring the rate of tryptic peptide release and (iv), locate sites of aberrant proteolysis seen when recombinant human TIMP-1 was purified at large scale.
R A Williamson, and
B J Smith, and
S Angal, and
G Murphy, and
R B Freedman
September 2001,
FEMS microbiology letters,
R A Williamson, and
B J Smith, and
S Angal, and
G Murphy, and
R B Freedman
January 2001,
Methods in molecular biology (Clifton, N.J.),
R A Williamson, and
B J Smith, and
S Angal, and
G Murphy, and
R B Freedman
October 1995,
Neurologia medico-chirurgica,
R A Williamson, and
B J Smith, and
S Angal, and
G Murphy, and
R B Freedman
January 1977,
Intervirology,
R A Williamson, and
B J Smith, and
S Angal, and
G Murphy, and
R B Freedman
July 1994,
The Journal of biological chemistry,
R A Williamson, and
B J Smith, and
S Angal, and
G Murphy, and
R B Freedman
December 1993,
Proteins,
R A Williamson, and
B J Smith, and
S Angal, and
G Murphy, and
R B Freedman
September 1994,
Biochimica et biophysica acta,
R A Williamson, and
B J Smith, and
S Angal, and
G Murphy, and
R B Freedman
June 2003,
International journal of cancer,
R A Williamson, and
B J Smith, and
S Angal, and
G Murphy, and
R B Freedman
October 2002,
Protein science : a publication of the Protein Society,
R A Williamson, and
B J Smith, and
S Angal, and
G Murphy, and
R B Freedman
January 2003,
Surgery today,
